Accuray Announces Approval of the Tomo® C Radiation Treatment Delivery System by China's National Medical Products Administration



MADISON, Wis., Oct. 3, 2023 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the CNNC-Accuray joint venture Tomo® C radiation therapy system for the Type B market has been approved by the Chinese National Medical Products Administration…

Leave a Reply